secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2026-05-14T23:31:55+00:00
Accession:  0001093557-26-000085
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

DexCom sets 10%+ annual organic revenue growth target through 2030; authorizes $1B share buyback
--------------------------------------------------------------------------------

- Long-range target: organic revenue growth 10%+ every year through 2030.
- 2030 non-GAAP gross profit margin target of 67-69%; operating margin 29-30%.
- 2030 adjusted EBITDA margin target of 36-37%.
- Board authorized $1.0B share repurchase program, expiring June 30, 2027.
- Prior $250M remaining buyback program terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000085/0001093557-26-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000085/dxcm-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001093557-26-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer